Answer Fibronectin glomerulopathy: the fibril in the mesangium
The differential diagnosis for the presence of massive mesangial deposits seen on light microscopy and of fibrillary ultrastructure on electron microscopy (EM) includes: amyloidosis, cryoglobulinemia, paraproteinemias, lymphoproliferative disorders, lupus, immunotactoid glomerulopathy, fibrillary glomerulonephritis and fibronectin glomerulopathy. The case's age and negative Congo Red staining make a diagnosis of amyloidosis unlikely, and the negative immunofluorescence for immunoglobulins and complement and negative immunohistochemistry (IHC) for kappa/lambda are inconsistent with the other aforementioned entities, with the exception of fibronectin glomerulopathy. Furthermore, the random orientation of the fibrils is not characteristic of immmunotactoid glomerulopathy and cryoglobulinemia. IHC for fibronectin was performed; the strong staining of the abnormal mesangial matrix ( Fig. 1 ) confirmed the diagnosis of fibronectin glomerulopathy.
Discussion
Fibronectin glomerulopathy is a rare glomerular disorder caused by extensive mesangial and subendothelial deposition of fibronectin. In a recent series, ten cases were identified from among 35,088 kidney biopsies performed from 2003 to 2012 [1] . Fibronectin is an extracellular protein involved in cellmatrix interactions and exists in two forms: a cellular form produced by mesangial cells and a circulating form produced by the liver. Findings indicate that the glomerular deposits are derived primarily from the plasma form [2] . Inheritance is autosomal dominant with age-related penetrance. In 2008, heterozygous mutations in the fibronectin gene FN1 were found in 40 % of families studied (6/15 pedigrees) [3] . The case's family history of long-standing hypertension and proteinuria in his mother and end-stage kidney disease (ESKD) in his maternal grandmother is consistent with this hereditary disorder. Given that his maternal grandmother never had a kidney biopsy, her ESKD may have been the result of fibronectin glomerulopathy rather than amyloidosis.
Individuals can present at any age, with reported age of onset ranging from 3 to 64 years [4] . The predominant clinical presentation is proteinuria, often nephrotic-range proteinuria, with or without hypertension, reduced kidney function, or microscopic hematuria. The characteristic biopsy findings, illustrated by this case, include: marked eosinophilic and periodic acidSchiff-positive mesangial and subendothelial deposits with glomerulomegaly and lobulation of tufts, negative Jones and Congo Red staining, and granular electron-dense mesangial and subendothelial deposits on EM, which may appear fibrillary. Progression to ESKD within 15-20 years is frequent [1, 2, 5, 6] . Recurrence after renal transplantation has been reported [6, 7] . Due to the limited data available on fibronectin glomerulopathy, therapeutic management is not well-defined. The current management approach is aimed at renoprotection with antiproteinuric and anti-hypertensive agents.
Fibronectin glomerulopathy should be considered in the differential diagnosis of significant proteinuria, particularly when features of marked glomerulomegaly and mesangial deposits are seen on biopsy. This case highlights the importance of recognizing this clinical entity in the pediatric population in whom other conditions associated with fibrillary electron dense deposits are very rare. 
